Mannitol 10 gm + glycerin 10 gm Infusion

Mannitol 10 gm + glycerin 10 gm Infusion is used for the control, treatment and prevention of dry skin, cold sores, and certain other skin diseases such as psoriasis. It is also often used in circumstances where the skin needs to be lubricated and moistened. Mannitol 10 gm + glycerin 10gm Infusion works by forming a protective film and helping moisturize the dry area, as well as improving blood circulation in the body.

Do not use  Mannitol 10 gm + glycerin 10 gm Infusion if you are allergic to any of the ingredients present in it, or if you are pregnant and/or breastfeeding. Before using Mannitol 10 gm + glycerin 10gm Infusion tell your doctor if you are using any prescription drugs, non-prescription drugs, or other herbal and dietary pills and supplements, or if you have recently had any surgeries, or have any upcoming surgeries scheduled. Also let your doctor know your history of medical problems, pre-existing diseases and current health conditions.Mannitol 10 gm + glycerin 10 gm Infusion  is administered via topical cream form, which has to be applied directly to the affected area. Dosage depends on conditions such as medical condition, diet, age, and counteraction with other medicines.

INDICATIONS

Mannitol I.V. (Mannitol  is indicated for the following purposes in adults and pediatric patients.

Therapeutic Use

1. Promotion of diuresis in the prevention or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established.
2. Reduction of intracranial pressure and brain mass.
3. Reduction of high intraocular pressure when the pressure cannot be lowered by other means.
4. Promotion of urinary excretion of toxic materials.

DOSAGE AND ADMINISTRATION

Mannitol I.V. (Mannitol  should be administered only by intravenous infusion. The total dosage, concentration and rate of administration should be governed by the nature and severity of the condition being treated, fluid requirement and urinary output. The usual adult dosage ranges from 50 to 200 g in a 24-hour period, but in most instances an adequate response will be achieved at a dosage of approximately 100 g/24 hours. The rate of administration is usually adjusted to maintain a urine flow of at least 30 to 50 mL/hr. The total dose should be adjusted according to the clinical response and adverse events.